These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 2106763
21. Effects of cadmium on osteoclast formation and activity in vitro. Wilson AK, Cerny EA, Smith BD, Wagh A, Bhattacharyya MH. Toxicol Appl Pharmacol; 1996 Oct; 140(2):451-60. PubMed ID: 8887463 [Abstract] [Full Text] [Related]
22. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants. van der Pluijm G, Löwik CW, de Groot H, Alblas MJ, van der Wee-Pals LJ, Bijvoet OL, Papapoulos SE. J Bone Miner Res; 1991 Nov; 6(11):1203-10. PubMed ID: 1839590 [Abstract] [Full Text] [Related]
23. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T. Bone; 1995 Aug; 17(2):137-44. PubMed ID: 8554921 [Abstract] [Full Text] [Related]
24. The effects of sodium fluoride on the resorptive activity of isolated osteoclasts. Okuda A, Kanehisa J, Heersche JN. J Bone Miner Res; 1990 Mar; 5 Suppl 1():S115-20. PubMed ID: 2339620 [Abstract] [Full Text] [Related]
25. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Vitté C, Fleisch H, Guenther HL. Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182 [Abstract] [Full Text] [Related]
26. The effect of fluoride on the resorption of dentine by osteoclasts in vitro. Taylor ML, Maconnachie E, Frank K, Boyde A, Jones SJ. J Bone Miner Res; 1990 Mar; 5 Suppl 1():S121-30. PubMed ID: 2339621 [Abstract] [Full Text] [Related]
27. [Possible mechanism of the specific action of bisphosphonates on osteoclasts]. Udagawa N. Nihon Rinsho; 2003 Feb; 61(2):207-12. PubMed ID: 12638209 [Abstract] [Full Text] [Related]
28. Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Sabokbar A, Fujikawa Y, Murray DW, Athanasou NA. Ann Rheum Dis; 1998 Oct; 57(10):614-8. PubMed ID: 9893573 [Abstract] [Full Text] [Related]
29. Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivo. van der Pluijm G, Binderup L, Bramm E, van der Wee-Pals L, De Groot H, Binderup E, Löwik C, Papapoulos S. J Bone Miner Res; 1992 Aug; 7(8):981-6. PubMed ID: 1442212 [Abstract] [Full Text] [Related]
30. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors. Amano S, Hanazawa S, Kawata Y, Ohta K, Kitami H, Kitano S. J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834 [Abstract] [Full Text] [Related]
31. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ. J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603 [Abstract] [Full Text] [Related]
36. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ. J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770 [Abstract] [Full Text] [Related]
37. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models. Azuma Y, Sato H, Oue Y, Okabe K, Ohta T, Tsuchimoto M, Kiyoki M. Bone; 1995 Feb; 16(2):235-45. PubMed ID: 7756053 [Abstract] [Full Text] [Related]